Johns Hopkins Medicine entered discussions to integrate with Sibley in May. The deal still requires regulatory approval. The FTC and the District of Columbia State Health Planning and Development Agency need to approve the deal, but the decisions are expected within several days.
If approved, the 328-bed Sibley would become a wholly owned subsidiary of Hopkins Medicine. The deal will not involve a money exchange.
Read more the Baltimore Sun report on Johns Hopkins’ acquisition of Sibley Memorial Hospital.
Read more about Johns Hopkins Medicine:
–Johns Hopkins Gets $3.84M Grant for Urban Health Program
–DC Hospital to Join Johns Hopkins
–Johns Hopkins’ Urban Health Program Gaining Momentum
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
